SCHEMBL23862832

SCHEMBL23862832

COC(=O)c1ccc(C2(N)CCN(C(C)=O)C2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 1/20 0.44
▸ ALDH1A1 P00352 4/20 0.42
▸ HPGD P15428 2/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ MGLL Q99685 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ EP300 Q09472 1/20 0.41
▸ CREBBP Q92793 1/20 0.41
▸ RAB9A P51151 2/20 0.40
▸ CYP2D6 P10635 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ AKT1 P31749 1/20 0.39
▸ AKT2 P31751 1/20 0.39
▸ CA1 P00915 2/20 0.39
▸ CA2 P00918 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL871865 0.79 CA1 (0.52) ALDH1A1RAB9ANPC1SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL871688 0.78 CA1 (0.50) ALDH1A1RAB9ANPC1SMN1; SMN2MAPT
SCHEMBL18662857 0.76 AKT1 (0.50) ALDH1A1MAPTAKT1AKT2CA1
SCHEMBL24861978 0.76 AKT1 (0.53) ALDH1A1MAPTAKT1AKT2CA1
SCHEMBL19343293 0.75 MEN1 (0.53) ALDH1A1HPGDCYP2D6MAPTMEN1
SCHEMBL2109932 0.74 STS (0.49) ALDH1A1HPGDRAB9AMAPTAKT1
SCHEMBL19331211 0.73 ALDH1A1 (0.50) ALDH1A1HPGDALOX15MGLLHSD17B10
SCHEMBL19343523 0.72 NPC1 (0.48) ALDH1A1HPGDALOX15MGLLHSD17B10
SCHEMBL647915 0.71 CRBN (0.53) CRBNALDH1A1HPGDALOX15MGLL
SCHEMBL20491450 0.71 RORC (0.44) ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3884939-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF Raze Therapeutics, Inc. (US) 2021-09-29 — — EP disclosed
Send feedback